Symmetry Medical Reports Full Year 2007 Financi...(10435 7264 2675 Total Sha...),Health
Navigation Links
Symmetry Medical Reports Full Year 2007 Financial Results
Date:4/23/2008
10,435 7,264 2,675
Total Shareholders' Equity 237,536 232,607 207,760
Total Liabilities and Shareholders'
Equity $400,430 $354,396 $293,045
'/>"/>
| SOURCE Symmetry Medical Inc. Copyright©2008 PR Newswire. All rights reserved |
Related medicine news :
1. Symmetry Medical Completes Acquisition Of Specialty Surgical Instruments
2. Symmetry Medical Launches New Global Web site
3. Symmetry Medical Appoints John Hynes Chief Operating Officer, Europe
4. Symmetry Medical Provides Update of Previously Disclosed Accounting Review at Sheffield, UK Operating Unit
5. Symmetry Medical Completes Acquisition of DePuy Orthopaedic Instrument Facility
6. Symmetry Medical to Provide Fourth Quarter 2007 General Business Update on February 14, 2008
7. Facial asymmetry persists despite surgery to correct congenital deformity
8. Symmetry Medical to Expand Malaysian Operations
9. Symmetry Medical Delays 10-K Filing to Complete Review
10. MSU engineering team designs innovative medical device
11. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
Post Your Comments:
Breaking Medicine News(10 mins):Health News:Study shows how gene action may lead to diabetes prevention, cure 2Health News:The Visiting Nurse Association of Greater Philadelphia Expands Service to Bucks County 2Health News:Autism Research at the Children's Hospital of Philadelphia Is Among Time Magazine's Top 10 Medical Breakthroughs 2Health News:IOM report on national vaccine plan 2Health News:IOM report on national vaccine plan 3Health News:New Drugs, New Combinations Fight Breast Cancer 2Health News:New Drugs, New Combinations Fight Breast Cancer 3
[0] Study shows how gene action may lead to diabetes prevention, cure[0] The Visiting Nurse Association of Greater Philadelphia Expands Service to Bucks County[0] Autism Research at the Children's Hospital of Philadelphia Is Among Time Magazine's Top 10 Medical Breakthroughs[0] IOM report on national vaccine plan[0] New Drugs, New Combinations Fight Breast Cancer
Other Medicine News:Health News:Tackling Obesity Through Education and FUNdraising 2Health News:Gender is a relative term in politics, MU study finds 2Health News:Occupational Therapy Plus Exercise Benefits Osteoarthritis 2Health News:Trinity Medical Center Announces Plans for Digital Hospital Site 2Health News:VOICES Report Tracks State Progress and Trends in Addressing Children's Critical Needs 2Health News:VOICES Report Tracks State Progress and Trends in Addressing Children's Critical Needs 3
Tackling Obesity Through Education and FUNdraisingInverness Medical Innovations to Present at the Third Annual JMP Securities Healthcare Focus Conference on October 7, 2008Gender is a relative term in politics, MU study findsOccupational Therapy Plus Exercise Benefits OsteoarthritisTrinity Medical Center Announces Plans for Digital Hospital SiteVOICES Report Tracks State Progress and Trends in Addressing Children's Critical Needs
Breaking Medicine Technology:ThromboGenics Announces Start of Phase II Trial of Microplasmin for the Treatment of Age-Related Macular Degeneration (AMD) 2ThromboGenics Announces Start of Phase II Trial of Microplasmin for the Treatment of Age-Related Macular Degeneration (AMD) 3ThromboGenics Announces Start of Phase II Trial of Microplasmin for the Treatment of Age-Related Macular Degeneration (AMD) 4Within3 Expands into Mobile Applications 2Federal Judge Rejects GlaxoSmithKline's Claims of Privilege 2Health Workers Face Postcode Lottery for Swine Flu Vaccine Chemist+Druggist Reveals 13835 1Health Workers Face Postcode Lottery for Swine Flu Vaccine Chemist+Druggist Reveals 13835 2Kroger Selects WaveSense Diabetes Testing Products 56156 1Kroger Selects WaveSense Diabetes Testing Products 56156 2K State host to World Rabies Day Symposium emphasizing 1 health strategy 56151 1
Other Medicine Technology:Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients 2Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients 3Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients 4Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients 5Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients 6Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients 7Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients 8Iomai and Merck & Co., Inc. Evaluate Use of Iomai Immunostimulant Patch 2Iomai and Merck & Co., Inc. Evaluate Use of Iomai Immunostimulant Patch 3
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |